冠心病血运重建后心脏性猝死的预防  

Prevention of sudden cardiac death after revascularization of coronary heart disease

作　　者：邵帅[1] 李广平[1] SHAO Shuai;LI Guang-ping(Department of Cardiology,the Second Hospital of Tianjin Medical University,Tianjin Key Laboratory of Ionic Molecular Function of Cardiovascular Disease,Tianjin Institute of Cardiology,Tianjin 300211,China)

机构地区：[1]天津医科大学第二医院心脏科,天津市心血管病离子与分子机能重点实验室,天津心脏病学研究所,天津300211

出　　处：《实用心电学杂志》2022年第1期60-64,共5页Journal of Practical Electrocardiology

基　　金：天津市教委科研计划项目(2020KJ167)。

摘　　要：植入式心脏除颤器(implantable cardioverter defibrillator,ICD)作为预防缺血性心肌病血运重建后心脏性猝死(sudden cardiac death,SCD)的主要手段,目前已广泛应用于临床,但临床医生仍不能准确把握其应用的时机以及适应证。本文就冠心病患者血运重建后SCD的发生情况以及ICD的应用进行综述,旨在强调ICD的正确及合理应用,以挽救更多患者的生命。Implantable cardioverter defibrillator(ICD)as the main therapy to prevent sudden cardiac death(SCD)after revascularization in patients with ischemic cardiomyopathy,has been widely used in clinic at present.However,the timing and indications of ICD application are still unclear for clinicians.This article reviews the incidence of SCD after revascularization in patients with coronary heart disease,and the application of ICD,in order to emphasize the correct and rational application of ICD for saving more lives of patients.

关 键 词：冠心病 经皮冠状动脉介入 冠状动脉搭桥术 心脏性猝死 植入式心脏复律除颤器 血运重建 

分 类 号：R541.4[医药卫生—心血管疾病]